Company Shanghai Labway Clinical Laboratory Co., Ltd

Equities

301060

CNE100004RG8

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Medical & Diagnostic Laboratories

SHANGHAI LABWAY CLINICAL LABORATORY CO., LTD

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 30/04/2024 am IST			5-day change	1st Jan Change
10.2 ^CNY	-0.49%		+12.09%	-23.25%

26/04	Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02/04	Tranche Update on Shanghai Labway Clinical Laboratory Co., Ltd's Equity Buyback Plan announced on November 16, 2023.	CI

Shanghai Labway Clinical Laboratory Co Ltd is a company providing overall solutions for the inspection and diagnosis industry. The Company's businesses include medical testing and pathological diagnosis services and the sales of in vitro diagnosis product. The medical examination and pathological diagnosis services include pathological diagnosis, molecular examination, biochemical examination, immune examination, microbial examination, clinical basic examination and physical and chemical examination. The in vitro diagnostic products sales include in vitro diagnostic instruments, reagents and related accessories and consumables.

Number of employees: 1,878

CNY in Million	2021	Weight	2022	Weight	Delta
Medical Diagnostic Services 77.6 %	947	53.3 %	3,259	77.6 %	+244.05%
In Vitro Diagnostic Product - Product Agent 18.2 %	819	46.1 %	766	18.2 %	-6.53%
In Vitro Diagnostic Product - Platform Service 3.7 %	-	-	157	3.7 %	-
Other 0.4 %	12	0.7 %	18	0.4 %	+46.94%

CNY in Million	2021	Weight	2022	Weight	Delta
China 100.0 %	1,778	100.0 %	4,199	100.0 %	+136.14%

Managers	Title	Age	Since
Wei Xiong Zeng CEO	Chief Executive Officer	56	20/15/20
Xi Gu Wang DFI	Director of Finance/CFO	54	22/22/22
Zhi Sen Mao BRD	Director/Board Member	64	17/21/17
Lin Jie Sun BRD	Director/Board Member	49	20/15/20
Jing Jing Yang IRC	Investor Relations Contact	-	-
Wen Jun Gao SEC	Corporate Secretary	41	18/17/18

Members of the board	Title	Age	Since
Lei Wang BRD	Director/Board Member	42	17/21/17
Wei Xiong Zeng CEO	Chief Executive Officer	56	20/15/20
Hui Juan Jing BRD	Director/Board Member	53	20/15/20
Lin Jie Sun BRD	Director/Board Member	49	20/15/20
Bao Hai Liu BRD	Director/Board Member	69	28/17/28
Guo Quan Liu CHM	Chairman	39	15/17/15
Jing Guo BRD	Director/Board Member	42	01/15/01
Zhi Sen Mao BRD	Director/Board Member	64	17/21/17
Ge Zhang BRD	Director/Board Member	38	22/22/22
Jian Zhu BRD	Director/Board Member	53	22/22/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	400,517,000	129,321,132 ( 32.29 %)	751,500 ( 0.1876 %)	32.29 %

Name	Equities	%	Valuation
Jian Ping Zhou 14.62 %	26,879,500	14.62 %	44 M ¥
Laibin Baizhi Commercial Center LP 6.535 %	12,015,000	6.535 %	20 M ¥
Shenzhen Fortune Caizhi Venture Capital Management Co., Ltd. 4.504 %	8,280,000	4.504 %	14 M ¥
Da You Duan 3.565 %	6,553,680	3.565 %	11 M ¥
Chun Fei Zhu 3.264 %	6,000,000	3.264 %	10 M ¥
Qiong You Fan 3.019 %	5,550,000	3.019 %	9 M ¥
ORIENT SECURITIES COMPANY LIMITED 2.910 %	5,349,000	2.910 %	9 M ¥
Hui Lian Yang 1.958 %	3,600,000	1.958 %	6 M ¥
Lin Jie Sun 0.4087 %	751,420	0.4087 %	1 M ¥
China Post & Capital Fund Management Co., Ltd. 0.3780 %	694,992	0.3780 %	1 M ¥

Name	Equities	%	Valuation
Lin Jie Sun 2.177 %	4,805,680	2.177 %	8 M ¥

Shanghai Labway Clinical Laboratory Co., Ltd.

Floor 6-9, Building 1 Lane 268, Linxin Road

200335, Shanghai

http://www.labway.cn

address Shanghai Labway Clinical Laboratory Co., Ltd(301060)

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SHANGHAI LABWAY CLINICAL LABORATORY CO., LTD	-23.25%	564M
SONIC HEALTHCARE LIMITED	-19.14%	8.22B
RADNET, INC.	+47.92%	3.73B
SYNLAB AG	-8.06%	2.46B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-38.71%	2.46B
DR. LAL PATHLABS LIMITED	-8.84%	2.36B
NEOGENOMICS, INC.	-12.55%	1.78B
FLEURY S.A.	-18.90%	1.52B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.78%	1.21B
METROPOLIS HEALTHCARE LIMITED	+8.32%	1.12B

Medical & Diagnostic Laboratories